Hormonal therapy of renal carcinoma alone and in association with cytostatic drugs.
D000328:Adult; D000368:Aged; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008875:Middle Aged; D011372:Progestins / Q000627:therapeutic use*; D011422:Propionates / Q000627:therapeutic use; D013739:Testosterone / Q000627:therapeutic use*; D014476:Undecylenic Acids / Q000627:therapeutic use; D014631:Valerates / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use*
D004338:Drug Combinations; D011372:Progestins; D011422:Propionates; D014476:Undecylenic Acids; D014631:Valerates; D013739:Testosterone; D014747:Vinblastine; D008525:Medroxyprogesterone; D005472:Fluorouracil